Embolic protection device does not reduce stroke rate in TAVR procedureA device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the rate of stroke, according to a randomized trial presented at the American College of Cardiology's Annual Scientific Session.
Source:
Embolic protection device does not reduce stroke rate in TAVR procedure